These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
604 related items for PubMed ID: 26702068
1. UCH-L1 is induced in germinal center B cells and identifies patients with aggressive germinal center diffuse large B-cell lymphoma. Bedekovics T, Hussain S, Feldman AL, Galardy PJ. Blood; 2016 Mar 24; 127(12):1564-74. PubMed ID: 26702068 [Abstract] [Full Text] [Related]
2. UCH-L1 in DLBCL: marker or target? Pagano JS, Shackelford J. Blood; 2016 Mar 24; 127(12):1524-5. PubMed ID: 27013211 [Abstract] [Full Text] [Related]
3. Loss of signalling via Gα13 in germinal centre B-cell-derived lymphoma. Muppidi JR, Schmitz R, Green JA, Xiao W, Larsen AB, Braun SE, An J, Xu Y, Rosenwald A, Ott G, Gascoyne RD, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Braziel RM, Tubbs RR, Cook JR, Weisenburger DD, Chan WC, Vaidehi N, Staudt LM, Cyster JG. Nature; 2014 Dec 11; 516(7530):254-8. PubMed ID: 25274307 [Abstract] [Full Text] [Related]
4. MYC/BCL6 double-hit lymphoma (DHL): a tumour associated with an aggressive clinical course and poor prognosis. Li S, Desai P, Lin P, Yin CC, Tang G, Wang XJ, Konoplev SN, Khoury JD, Bueso-Ramos CE, Medeiros LJ. Histopathology; 2016 Jun 11; 68(7):1090-8. PubMed ID: 26426741 [Abstract] [Full Text] [Related]
5. Clinical Significance of BCL2, C-MYC, and BCL6 Genetic Abnormalities, Epstein-Barr Virus Infection, CD5 Protein Expression, Germinal Center B Cell/Non-Germinal Center B-Cell Subtypes, Co-expression of MYC/BCL2 Proteins and Co-expression of MYC/BCL2/BCL6 Proteins in Diffuse Large B-Cell Lymphoma: A Clinical and Pathological Correlation Study of 120 Patients. Ting CY, Chang KM, Kuan JW, Sathar J, Chew LP, Wong OJ, Yusuf Y, Wong L, Samsudin AT, Pana MNBM, Lee SK, Gopal NSR, Puri R, Ong TC, Bahari SK, Goh AS, Teoh CS. Int J Med Sci; 2019 Jun 11; 16(4):556-566. PubMed ID: 31171907 [Abstract] [Full Text] [Related]
6. Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma. Xu-Monette ZY, Li L, Byrd JC, Jabbar KJ, Manyam GC, Maria de Winde C, van den Brand M, Tzankov A, Visco C, Wang J, Dybkaer K, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, Hsi ED, Choi WW, Huh J, Ponzoni M, Ferreri AJ, Møller MB, Parsons BM, Winter JN, Wang M, Hagemeister FB, Piris MA, Han van Krieken J, Medeiros LJ, Li Y, van Spriel AB, Young KH. Blood; 2016 Dec 29; 128(26):3083-3100. PubMed ID: 27760757 [Abstract] [Full Text] [Related]
7. Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas. Georgiou K, Chen L, Berglund M, Ren W, de Miranda NF, Lisboa S, Fangazio M, Zhu S, Hou Y, Wu K, Fang W, Wang X, Meng B, Zhang L, Zeng Y, Bhagat G, Nordenskjöld M, Sundström C, Enblad G, Dalla-Favera R, Zhang H, Teixeira MR, Pasqualucci L, Peng R, Pan-Hammarström Q. Blood; 2016 Jun 16; 127(24):3026-34. PubMed ID: 27030389 [Abstract] [Full Text] [Related]
8. [Immunophenotypes and prognosis of diffuse large B-cell lymphoma: a study of 500 cases]. Luo DL, Liu YH, Zhuang HG, Li L, Xu FP, Zhang F, Luo XL, Xu J. Zhonghua Bing Li Xue Za Zhi; 2011 Apr 16; 40(4):235-9. PubMed ID: 21615996 [Abstract] [Full Text] [Related]
9. PRMT5 is upregulated by B-cell receptor signaling and forms a positive-feedback loop with PI3K/AKT in lymphoma cells. Zhu F, Guo H, Bates PD, Zhang S, Zhang H, Nomie KJ, Li Y, Lu L, Seibold KR, Wang F, Rumball I, Cameron H, Hoang NM, Yang DT, Xu W, Zhang L, Wang M, Capitini CM, Rui L. Leukemia; 2019 Dec 16; 33(12):2898-2911. PubMed ID: 31123343 [Abstract] [Full Text] [Related]
10. Immunohistochemical classification of de novo, transformed, and relapsed diffuse large B-cell lymphoma into germinal center B-cell and nongerminal center B-cell subtypes correlates with gene expression profile and patient survival. Haarer CF, Roberts RA, Frutiger YM, Grogan TM, Rimsza LM. Arch Pathol Lab Med; 2006 Dec 16; 130(12):1819-24. PubMed ID: 17149956 [Abstract] [Full Text] [Related]
11. Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma. Chen J, Xu-Monette ZY, Deng L, Shen Q, Manyam GC, Martinez-Lopez A, Zhang L, Montes-Moreno S, Visco C, Tzankov A, Yin L, Dybkaer K, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, Hsi ED, Choi WW, van Krieken JH, Huh J, Ponzoni M, Ferreri AJ, Zhao X, Møller MB, Farnen JP, Winter JN, Piris MA, Pham L, Young KH. Oncotarget; 2015 Mar 20; 6(8):5597-614. PubMed ID: 25704881 [Abstract] [Full Text] [Related]
12. Primary Bone Lymphoma Exhibits a Favorable Prognosis and Distinct Gene Expression Signatures Resembling Diffuse Large B-Cell Lymphoma Derived From Centrocytes in the Germinal Center. Li X, Xu-Monette ZY, Yi S, Dabaja BS, Manyam GC, Westin J, Fowler N, Miranda RN, Zhang M, Ferry JA, Medeiros LJ, Harris NL, Young KH. Am J Surg Pathol; 2017 Oct 20; 41(10):1309-1321. PubMed ID: 28817403 [Abstract] [Full Text] [Related]
13. MYC translocation and an increased copy number predict poor prognosis in adult diffuse large B-cell lymphoma (DLBCL), especially in germinal centre-like B cell (GCB) type. Yoon SO, Jeon YK, Paik JH, Kim WY, Kim YA, Kim JE, Kim CW. Histopathology; 2008 Aug 20; 53(2):205-17. PubMed ID: 18752503 [Abstract] [Full Text] [Related]
14. A super-SILAC based proteomics analysis of diffuse large B-cell lymphoma-NOS patient samples to identify new proteins that discriminate GCB and non-GCB lymphomas. van der Meeren LE, Kluiver J, Rutgers B, Alsagoor Y, Kluin PM, van den Berg A, Visser L. PLoS One; 2019 Aug 20; 14(10):e0223260. PubMed ID: 31603917 [Abstract] [Full Text] [Related]
15. BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma. Iqbal J, Sanger WG, Horsman DE, Rosenwald A, Pickering DL, Dave B, Dave S, Xiao L, Cao K, Zhu Q, Sherman S, Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Ott G, Müller-Hermelink HK, Delabie J, Braziel RM, Jaffe ES, Campo E, Lynch JC, Connors JM, Vose JM, Armitage JO, Grogan TM, Staudt LM, Chan WC. Am J Pathol; 2004 Jul 20; 165(1):159-66. PubMed ID: 15215171 [Abstract] [Full Text] [Related]
16. Distinct IL-4-induced gene expression, proliferation, and intracellular signaling in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas. Lu X, Nechushtan H, Ding F, Rosado MF, Singal R, Alizadeh AA, Lossos IS. Blood; 2005 Apr 01; 105(7):2924-32. PubMed ID: 15591113 [Abstract] [Full Text] [Related]
17. Immunohistochemical expression of mTOR in germinal center and nongerminal center group of diffuse large B-cell lymphoma: a clinicopathological study. Vajpayee N, Burack R, Wang D, Hutchison RE, Gajra A. Clin Lymphoma Myeloma Leuk; 2015 Mar 01; 15(3):159-63. PubMed ID: 25458080 [Abstract] [Full Text] [Related]
18. [Prevalence of germinal center B-cell-like and non-germinal center B-cell-like types of diffuse large B-cell lymphoma in Shanghai, China]. Chen Y, Chen H, Fu K, Zhu XZ, Irons R. Zhonghua Bing Li Xue Za Zhi; 2010 May 01; 39(5):313-8. PubMed ID: 20654154 [Abstract] [Full Text] [Related]
19. Primary central nervous system diffuse large B-cell lymphoma shows an activated B-cell-like phenotype with co-expression of C-MYC, BCL-2, and BCL-6. Li X, Huang Y, Bi C, Yuan J, He H, Zhang H, Yu Q, Fu K, Li D. Pathol Res Pract; 2017 Jun 01; 213(6):659-665. PubMed ID: 28552541 [Abstract] [Full Text] [Related]
20. A 9 series microRNA signature differentiates between germinal centre and activated B-cell-like diffuse large B-cell lymphoma cell lines. Culpin RE, Proctor SJ, Angus B, Crosier S, Anderson JJ, Mainou-Fowler T. Int J Oncol; 2010 Aug 01; 37(2):367-76. PubMed ID: 20596664 [Abstract] [Full Text] [Related] Page: [Next] [New Search]